AmeriPath Announces Changes to Board of Directors.Business Editors/Health Writers RIVIERA BEACH, Fla.--(BUSINESS WIRE)--Dec. 20, 2001 AmeriPath, Inc. (Nasdaq:PATH), one of the nation's leading providers of anatomic pathology services, today announced the appointments of Dennis M. Smith, Jr., M.D. and James T. Kelly to its Board of Directors. The appointments were made to fill vacancies created by the resignations of Alan Levin, M.D. and E. Roe Stamps, IV, who have served as directors since 1996. Dr. Levin's and Mr. Stamps' active board participation and business experience have been instrumental in developing and executing the Company's strategic plan during the past five years. Dr. Levin, the Company's Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , will be moving into the role of Corporate Vice President and practicing pathologist. This new assignment, reporting to the Company's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , James C. New, and developed at Dr. Levin's request, will allow him to focus on physician relations and communications throughout the Company. The Company's President, Brian Carr, will take over Dr. Levin's COO duties. Mr. Kelly served as the Chief Executive Officer of Lincare Holdings Inc. from 1986 through 1996, and served as Chairman of the Board of Lincare from 1994 through 2000. Prior to joining Lincare in 1986, Mr. Kelly spent 19 years with the Mining and Metals Division of Union Carbide Corporation, serving in a number of sales, operations and finance positions. Mr. Kelly is currently a director of American Dental Partners, Inc. and Health Management Systems, Inc. Dr. Smith is the Executive Vice President of Genomic Strategies and Chief Medical Officer of AmeriPath. He also holds the position of Managing Director of AmeriPath Laboratory Physicians, Jacksonville. Currently, Dr. Smith sits on the Board of Trustees board of trustees Politics The posse of thugs who oversee an institution's administration. See Board of directors. of the National Blood Foundation and on the Board of Directors of the Florida-Georgia Blood Alliance. He is also a member of the Vanderbilt University School of Engineering's Committee of Visitors. Dr. Smith was previously President of the American Association of Blood Banks, Director and Executive Head of the American Red Cross American Red Cross: see Red Cross. Blood Services, Nashville Region, Chairman of the National Blood Foundation, and a member of the Board of Directors of Immucor, Inc. AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. In the first nine months of 2001, AmeriPath diagnosed 2.9 million tissue biopsies, and interpreted 1.6 million Pap smears. The Company's extensive diagnostics infrastructure includes over 400 pathologists and doctorate-level scientists providing services to 42 independent pathology laboratories, 237 hospitals, the Center for Advanced Diagnostics (CAD), and Dermpath Diagnostics. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun) 1. crossbreeding; the act or process of producing hybrids. 2. molecular hybridization 3. (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is (PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) ), Molecular Genetics, Cytogenetics cytogenetics /cy·to·ge·net·ics/ (-je-net´iks) the branch of genetics devoted to cellular constituents concerned in heredity, i.e. chromosomes. , and HPV HPV human papillomavirus. HPV abbr. human papilloma virus Human papilloma virus (HPV) Typing. Dermpath Diagnostics, with over 60 board-certified dermatopathologists, is one of the country's leading providers of dermatopathology services in the growing skin diagnostic testing market. Additionally, AmeriPath provides clinical trial and research and development support to firms involved in developing new cancer and genomic diagnostics and therapeutics. Editor's Note: This release is also available at http://www.ameripath.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion